Orgenesis Inc. (ORGS) Financials
ORGS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-08-31 | 45.3 million | 32.9 million |
| 2023-05-31 | 54.8 million | 30.8 million |
| 2023-02-28 | 90.9 million | 31.7 million |
| 2022-11-30 | 90.9 million | 31.7 million |
ORGS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-08-31 | -1.5 million | 76000 |
| 2023-05-31 | -6.4 million | 152000 |
| 2023-02-28 | -16.2 million | 288000 |
| 2022-11-30 | -16.2 million | 288000 |
ORGS Net Income
No data available :(
ORGS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-08-31 | 55000 | - | 385000 |
| 2023-05-31 | 180000 | - | 469000 |
| 2023-02-28 | 5.3 million | - | 3.0 million |
| 2022-11-30 | - | - | 2.4 million |
ORGS Shares Outstanding
ORGS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-08-31 | 300000 | 808000 | 1.2 million | 64000 |
| 2023-05-31 | 511000 | 3.7 million | 3.2 million | 151000 |
| 2023-02-28 | 5.4 million | 27.1 million | 7.0 million | 5.4 million |
| 2022-11-30 | 5.4 million | 6.1 million | 7.0 million | - |
ORGS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-08-31 | 110000 | 139000 |
| 2023-05-31 | 7.0 million | 3.2 million |
| 2023-02-28 | 13.6 million | -51000 |
| 2022-11-30 | 13.6 million | -51000 |
ORGS
Price: $0.53
52 week price:
Earnings Per Share: -1.91 USD
P/E Ratio: -0.34
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 23800
Market Capitalization: 17.9 million